Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stoner, G. D.
Right arrow Articles by Gupta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoner, G. D.
Right arrow Articles by Gupta, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 11, 1737-1746, November 2001
© 2001 Oxford University Press


COMMENTARY

Etiology and chemoprevention of esophageal squamous cell carcinoma

Gary D. Stoner,1 and Ashok Gupta

Division of Environmental Health Sciences, The Ohio State University School of Public Health and The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Suite 1148B, 300 West 10th Avenue, Columbus, OH 43210, USA

Squamous cell carcinoma (SCC) of the human esophagus has a multifactorial etiology involving several environmental and/or genetic factors. Current modalities of therapy for this disease offer poor survival and cure rates. Although a number of approaches could be undertaken to reduce the occurrence of esophageal SCC, including changes in lifestyle and improved nutrition, such approaches are not easily implemented. Chemoprevention offers a viable alternative that is likely to be effective against this disease. Clinical investigations in areas of high incidence of esophageal SCC have shown that primary chemoprevention of this disease is feasible, if potent inhibitors are identified. Studies in the Fischer 344 rat model of nitrosamine-induced tumorigenesis have proven valuable in understanding the biology of esophageal SCCs and help identify surrogate end-point biomarkers and putative agents that can be useful in human chemoprevention studies. Several compounds that inhibit tumor initiation by suspected human esophageal carcinogens have been identified using this model. These include diallyl sulfide, isothiocyanates and several polyphenolic compounds. Novel biomarkers, including nuclear/nucleolar morphometry using computer-assisted image analysis of preneoplastic lesions, have been developed to measure efficacy of chemopreventive agents against esophageal SCC. The identification of single agents that inhibit the progression of dysplastic lesions, however, has proven difficult. Results from a food-based approach suggest that the use of freeze-dried berry preparations can affect both initiation and promotion/progression of esophageal SCC in an animal model. These observations provide valuable information for future studies on chemoprevention of cancers of the esophagus in a clinical setting. Given the complex etiology of esophageal SCC, it is felt that the most effective chemoprevention strategies would include agents that reduce mutational events associated with carcinogen exposure in combination with agents that inhibit the progression of intraepithelial dysplasia to invasive cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y.-Z. Deng, P.-P. Chen, Y. Wang, D. Yin, H. P. Koeffler, B. Li, X.-J. Tong, and D. Xie
Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through -Catenin-T-cell Factor/Lef Signaling
J. Biol. Chem., December 14, 2007; 282(50): 36571 - 36581.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. K. Reen, A. A. Dombkowski, L. A. Kresty, D. Cukovic, J. M. Mele, S. Salagrama, R. Nines, and G. D. Stoner
Effects of Phenylethyl Isothiocyanate on Early Molecular Events in N-Nitrosomethylbenzylamine-Induced Cytotoxicity in Rat Esophagus
Cancer Res., July 1, 2007; 67(13): 6484 - 6492.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Cao, X. Xu, L. L. Cao, R.-H. Wang, X. Coumoul, S. S. Kim, and C.-X. Deng
Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach
Carcinogenesis, July 1, 2007; 28(7): 1401 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Huang, Z. D. Liang, T.-T. Wu, A. Hoque, H. Chen, Y. Jiang, H. Zhang, and X.-c. Xu
Tumor-Suppressive Effect of Retinoid Receptor-Induced Gene-1 (RRIG1) in Esophageal Cancer
Cancer Res., February 15, 2007; 67(4): 1589 - 1593.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht, C. Huang, G. D. Stoner, J. Li, P. M.J. Kenney, S. J. Sturla, and S. G. Carmella
Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NF{kappa}B and AP-1 activity
Carcinogenesis, August 1, 2006; 27(8): 1617 - 1626.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Li, X. Zhang, G. Huang, X. Miao, L. Guo, D. Lin, and S.-H. Lu
Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma
Carcinogenesis, April 1, 2006; 27(4): 798 - 802.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. D. Stoner, H. Qin, T. Chen, P. S. Carlton, M. E. Rose, R. M. Aziz, and R. Dixit
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis
Carcinogenesis, September 1, 2005; 26(9): 1590 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. C Whitley, D. H. Sweet, and T. Walle
THE DIETARY POLYPHENOL ELLAGIC ACID IS A POTENT INHIBITOR OF hOAT1
Drug Metab. Dispos., August 1, 2005; 33(8): 1097 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. R. Olliver, L. J. Hardie, Y. Gong, S. Dexter, D. Chalmers, K. M. Harris, and C. P. Wild
Risk Factors, DNA Damage, and Disease Progression in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 620 - 625.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. H.-X. Xia, S. T. Zhang, S. K. Lam, M. C.-M. Lin, H. F. Kung, and B. C.-Y. Wong
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs
Carcinogenesis, January 1, 2005; 26(1): 11 - 15.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Chen, R. G. Nines, S. M. Peschke, L. A. Kresty, and G. D. Stoner
Chemopreventive Effects of a Selective Nitric Oxide Synthase Inhibitor on Carcinogen-Induced Rat Esophageal Tumorigenesis
Cancer Res., May 15, 2004; 64(10): 3714 - 3717.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X.-H. Tang, B. Knudsen, D. Bemis, S. Tickoo, and L. J. Gudas
Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice
Clin. Cancer Res., January 1, 2004; 10(1): 301 - 313.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.